While studies have linked PD-L1 overexpression to poorer prognosis, no study has demonstrated an association between PD-1 or CTLA-4 gene expression in PBMCs and survival outcomes in HCC patients [15,16,17]. The gene discussed is CTLA4; the disease is hepatocellular carcinoma.